en · de · es · fr · pt
sr9009-notes.peptides3626.com › Topic › Background And Receptor Mechanism — Common Mistakes

Background And Receptor Mechanism — Common Mistakes

By Editorial Desk · published 2025-12-10 · last reviewed 2025-12-27 · Topic

A practical reference on research compound: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

Reviewed 2025-12-27. Anything still debated is marked as such rather than presented as settled.

Background and Receptor Mechanism

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.

At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.

Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.

Background and Research Status

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.

REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.

Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.

Sr9009 at a glance

PropertyValueNotes
Chemical classSynthetic small moleculeStudied as a REV-ERB agonist
Molecular formulaC20H24ClN3O4SReported for the neutral compound
AppearanceOff-white to pale yellow solidTypical research-grade material
SolubilitySparingly soluble in waterSoluble in solvents such as DMSO
Common synonymsSR9009; StenabolicStenabolic is an informal alias

Identity, Handling, and Regulation

Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.

Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.

Related pages on this site

Regulation, Testing, and Storage

Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.

SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.

Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.

Notes from published material

=== February === February 1 Oregon Measure 110 comes into effect, making Oregon the first state to decriminalize the possession of small quantities of all illicit drugs. Actress Evan Rachel Wood alleges that Marilyn Manson sexually abused and groomed her as a teenager. Four other women make similar claims while Manson denies the allegations. The next day, February 2, Manson is dropped by his record label, Loma Vista Recordings, and removed from two TV shows: American Gods and Creepshow. February 2 2021 Sunrise, Florida shootout: During the service of a warrant, a suspect kills two FBI agents and injures three others before barricading himself inside his home. He is later found dead, reportedly from a self-inflicted gunshot wound. The shootout was the most violent incident in the FBI's history since 1986. The United States Senate votes 50–49 to pass a budget resolution that would allow Democrats to pass President Biden's $1.9 trillion relief package without support from Republicans. Three days later, February 5, the Senate passes a $1.9 trillion budget for COVID-19 relief. The 50–50 tie-breaker vote is broken by Vice President Kamala Harris. Amazon founder and CEO Jeff Bezos steps down after more than 26 years to focus on Blue Origin and names Amazon Web Services CEO Andy Jassy as his successor.

Ordinary silica-based reversed-phase columns work best in a moderate pH range. At very low pH or very high pH, the silica surface and the bonded hydrophobic layer can degrade. For RP-LC at very acidic or alkaline conditions, one can use hydrophobic polymeric particles, or hybridized silica-organic groups particles. Hydrophobic polymeric particles are made from an organic polymer instead of silica. A common example is polystyrene-divinylbenzene (PS-DVB). The particle itself is hydrophobic, so organic compounds can adsorb to it directly. Pure silica dissolves in alkaline conditions. Hybrid silica-organic particles are particles whose framework contains both silica units and organic groups. A typical structure is something like: Si–O–Si mixed with Si–R–Si, where R is an organic linker, such as an ethylene group. This makes the particle more resistant to alkaline conditions. The mobile phases are mixtures of water and polar organic solvents, usually methanol and acetonitrile. These mixtures usually contain various additives such as buffers (acetate, phosphate, citrate), surfactants (alkyl amines or alkyl sulfonates) and special additives (EDTA). The goal of using supplements of one kind or another is to increase efficiency, selectivity, and control solute retention.

=== Further manifestations of solvent hydrogen bonding === Increase in the melting point, boiling point, solubility, and viscosity of many compounds can be explained by the concept of hydrogen bonding. Negative azeotropy of mixtures of HF and water. The fact that ice is less dense than liquid water is due to a crystal structure stabilized by hydrogen bonds. Dramatically higher boiling points of NH3, H2O, and HF compared to the heavier analogues PH3, H2S, and HCl, where hydrogen-bonding is absent. Viscosity of anhydrous phosphoric acid and of glycerol. Dimer formation in carboxylic acids and hexamer formation in hydrogen fluoride, which occur even in the gas phase, resulting in gross deviations from the ideal gas law. Pentamer formation of water and alcohols in apolar solvents.

Sources: en.wikipedia.org

Further detail

In response to declining sales, in 2017 the company launched a fast casual spinoff of its format called "Hoots". Hoots is distinguished from its original concept primarily by a reduction in menu items and employment of both male and female servers who are modestly dressed in t-shirts and khakis.

==== Infections: HIV-AIDS, measles, RSV, others ==== The role of SP in HIV-AIDS has been well-documented. Doses of aprepitant greater than those tested to date are required for demonstration of full efficacy. Respiratory syncytial and related viruses appear to upregulate SP receptors, and rat studies suggest that NK1RAs may be useful in treating or limiting long term sequelae from such infections. Entamoeba histolytica is a unicellular parasitic protozoan that infects the lower gastrointestinal tract of humans. The symptoms of infection are diarrhea, constipation, and abdominal pain. This protozoan was found to secrete serotonin as well as Substance P and neurotensin.

Systematic doping in Russian sports has resulted in 47 Olympic and tens of world championships medals being stripped from Russian competitors—the most of any country, more than four times the number of the runner-up, and more than 30% of the global total. Russia also has the most competitors that have been caught doping at the Olympic Games, with more than 200. Russian doping is distinct from doping in other countries because in Russia the state supplied steroids and other drugs to sportspeople. Due to widespread doping violations, including an attempt to sabotage ongoing investigations by the manipulation of computer data, on 9 December 2019 the World Anti-Doping Agency (WADA) banned Russia from all international sport for four years. As at the 2018 Winter Olympics, WADA will allow individual cleared Russian athletes to compete neutrally under a title to be determined (which may not include the name "Russia", unlike the use of "Olympic Athletes from Russia" in 2018). Russia later filed an appeal to the Court of Arbitration for Sport (CAS) against the WADA decision. The Court of Arbitration for Sport, on review of Russia's appeal of its case from WADA, ruled on 17 December 2020 to reduce the penalty that WADA had imposed. Instead of banning Russia from sporting events, the ruling allowed Russia to participate at the Olympics and other international events, but for a period of two years the team cannot use the Russian name, flag, or anthem and must present themselves as "Neutral Athlete" or "Neutral Team".

Afterwards, Xi gave a speech, stating he was glad to visit the "beautiful" United States, thanked Trump for the hospitality and said "On behalf of the 1.4 billion and more Chinese people, I wish to begin by extending sincere greetings to the American people and the warm congratulations on the 250th anniversary of the US independence". He said both countries are great countries with great people, and that he was visiting to continue the friendship and expand co-operation. He added that as two major countries, China and the US show "their historic responsibility of advancing human development and progress". He also said that he is ready to "work with Trump to steer the giant ship of the China-US relationship towards a steady future". Xi said that "China and the US are different... but through candid, in-depth, and continued dialogue, our two countries can understand each other better... and build up mutual trust". He stated he and Trump had "respect" for each other and stayed in touch, and that "We should co-operate with sincerity". He said even though cooperation between the two nations "may not solve every problem in the world", it would be hard to solve major problems without it.

Sources: en.wikipedia.org

Supporting material

This mechanism of the neonatal FcRn involves albumin binding to the FcRn in an acidic pH environment to divert it from degradation in the lysosomal compartment of the cell, and redirecting it to the plasma membrane, where it is released back into the blood plasma due to neutral pH. Lipidation is a further technique to use when improving peptide stability and half-life. Attaching a lipid chain to the peptide head group has been found to inhibit proteolytic attack due to the lipid chain non-covalently interacting with serum albumin to increase the molecular weight, thus reducing renal filtration. Studies on a lipidated analogue of insulin, detemir, revealed a prolonged action as a result of its affinity for human serum albumin. As well as this, lipidation has been shown to enhance the interaction of peptides with cell membranes, allowing them to be up taken into the cell more readily compared to the peptide lacking the lipid moiety. There are three types of lipidation, and they differ based on the bond formation methods between the lipid and the peptide: amidation, esterification (S- or O-) and S-bond (ether or disulphide) formation. Amidation and O-esterification form strong covalent bonds that are irreversible, whereas the other two methods are weak and reversible covalent bonds. The method used, as well as the alkyl/lipid chain, position of lipidation, and the spacer used, all have significant impacts on physiochemical properties and bioactivity.

=== Diet === Changes in diet may help prevent the development of atherosclerosis. Tentative evidence suggests that a diet containing dairy products has no effect on or decreases the risk of cardiovascular disease. A diet rich in fruits and vegetables lowers the risk of cardiovascular disease and death. Evidence suggests that the Mediterranean diet may improve cardiovascular results. There is also evidence that a Mediterranean diet may be better than a low-fat diet in bringing about long-term changes to cardiovascular risk factors (e.g., lower cholesterol level and blood pressure). A 2024 review highlighted that bioactive compounds found in Mediterranean diet components (such as olive, grape, garlic, rosemary, and saffron) exhibit properties that may contribute to cardiovascular health and atherosclerosis prevention.

(–NS(Cl)–)3 + 3 NaOR → (–NS(OR)–)3 + 3 NaCl (–NS(Cl)–)3 + 3 AgX → (–NS(X)–)3 + 3 AgCl Treating thiazyl chloride with sulfur in the presence of antimony pentachloride gives dithionitronium hexachloroantimonate:

Deka Bike Robo (デカバイクロボ, Deka Baiku Robo): The Deka Bike's Tokusou Transformation and Deka Break's personal giant robot that is equipped with the twin wrist-mounted Sleeve Swords (スリーブソード, Surību Sōdo), which allow it to perform the Sword Tornado (ソードトルネード, Sōdo Torunēdo) finisher. Deka Wing Robo (デカウィングロボ, Deka Wingu Robo): The Dekarangers' second giant robot composed of the Pat Wings that dual wields the twin Pat Magnum (パトマグナム, Pato Magunamu) handguns, specializes in aerial and zero-g combat, and can perform the Double Heel Smash (ダブルヒールスマッシュ, Daburu Hīru Sumasshu) attack. It can also transform further into the Deka Wing Cannon (デカウィングキャノン, Deka Wingu Kyanon) to perform the Final Buster (ファイナルバスター, Fainaru Basutā) finisher on its own; the All Star Ultimate Buster (オールスター・アルティメットバスター, Ōru Sutā Arutimetto Basutā) finisher with Dekaranger Robo, Deka Bike Robo, and Deka Base Robo; and the Twin Robo Ultimate Buster (ツインロボ・アルティメットバスター, Tsuin Robo Arutimetto Basutā) with Deka Bike Robo. In the crossover film Mahō Sentai Magiranger vs. Dekaranger, the Deka Wing Cannon performs the Magi Final Buster (マジファイナルバスター, Maji Fainaru Basutā) finisher alongside the Magirangers' giant robot Magi Legend.

=== Graphic content === In June 2021, TikTok made an apology after a shock video, showing a girl dancing which then cuts to a graphic scene of a man being beheaded by a saw, went viral. The video has been put on TikTok's blacklist, which detects it before being uploaded. TikTok has previously worked to remove graphic content from its platform, including a suicide video that circulated in September 2020, which had appeared among the recommended clips of TikTok's For You section.

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

SR9009 is a synthetic research compound that activates the REV-ERBα and REV-ERBβ nuclear receptors. It is not an approved drug and has no established human therapeutic use. Most published biological data come from cell and rodent studies.

Is SR9009 a SARM?

No. SR9009 is frequently mislabeled as a SARM in online discussions, but it does not target androgen receptors. Its known mechanism involves REV-ERB nuclear receptors and circadian-metabolic gene regulation.

What human data exist for SR9009?

Human clinical data are very limited. There is no approved human use, and safety and efficacy in people are not established. Most evidence comes from preclinical models, so effects observed in animals may not apply to humans.

What is SR9009?

It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.

Network